Monthly Archives: September 2007

A new study found that the number of child and adolescent visits
to a doctor’s office that result in a diagnosis of bipolar disorder
has increased by 40 times over the decade from 1994-2003. Continue reading →

Anthony S. Fauci, M.D., director of the National Institute of
Allergy and Infectious Diseases (NIAID) of the National Institutes
of Health (NIH), has been awarded the 2007 Mary Woodard Lasker
Award for Public Service for his role in developing two major U.S.
public health programs, in AIDS and biodefense. The award will
be presented on Friday, September 28th during a luncheon ceremony
in New York City. Continue reading →

Dr. Nora Volkow, Director of the National
Institute on Drug Abuse (NIDA), part of the National Institutes
of Health (NIH) in Bethesda, Maryland, USA, will speak at
the 2007 World Psychiatric (WPA) Regional Meeting & Chinese
Society of Psychiatry (CSP) Annual Congress in Shanghai in
September. The meeting will provide a special opportunity
to discuss some of the most important topics of the psychiatric
field within an international framework. Such topics will
cover forensic psychiatry, clinical diagnosis, approaches
to care, and cultural issues. Continue reading →

A genetic variant present in nearly half of Americans of European
ancestry is linked to greater effectiveness of the smoking cessation
medication bupropion (Zyban), according to research by scientists
supported by the National Institute on Drug Abuse (NIDA) and the
National Cancer Institute (NCI), part of the National Institutes
of Health (NIH). People with this variant were less likely than
those without it to have resumed smoking six months after treatment
with bupropion. Continue reading →

More than 20 million adults in the United States are living with
diabetes and are at increased risk of cardiovascular disease (CVD).
But there are steps that they can take to reduce the complications
associated with these two diseases. The National Diabetes Education
Program (NDEP) has launched “Control Your Diabetes. For Life.”,
a national campaign that will reach out through a network of 200
partners to health care professionals and their patients to emphasize
the importance of comprehensive control of diabetes and CVD. The
NDEP is jointly sponsored by the National Institutes of Health
and the Centers for Disease Control and Prevention. Continue reading →

More than 20 million adults in the United States are living with
diabetes and are at increased risk of cardiovascular disease (CVD).
But there are steps that they can take to reduce the complications
associated with these two diseases. The National Diabetes Education
Program (NDEP) has launched ,
a national campaign that will reach out through a network of 200
partners to health care professionals and their patients to emphasize
the importance of comprehensive control of diabetes and CVD. The
NDEP is jointly sponsored by the National Institutes of Health
and the Centers for Disease Control and Prevention. Continue reading →

The medication tamoxifen, best known as a treatment for breast
cancer, dramatically reduces symptoms of the manic phase of bipolar
disorder more quickly than many standard medications for the mental
illness, a new study shows. Researchers at the National Institutes
of Health’s National Institute of Mental Health (NIMH) who conducted
the study also explained how: Tamoxifen blocks an enzyme called
protein kinase C (PKC) that regulates activities in brain cells.
The enzyme is thought to be over-active during the manic phase
of bipolar disorder. Continue reading →

The medication tamoxifen, best known as a treatment for breast
cancer, dramatically reduces symptoms of the manic phase of bipolar
disorder more quickly than many standard medications for the mental
illness, a new study shows. Researchers at the National Institutes
of Health’s National Institute of Mental Health (NIMH) who conducted
the study also explained how: Tamoxifen blocks an enzyme called
protein kinase C (PKC) that regulates activities in brain cells.
The enzyme is thought to be over-active during the manic phase
of bipolar disorder. Continue reading →

The National Institutes of Health (NIH) and NASA have entered into an agreement that helps American scientists utilize the International Space Station to answer questions about human health and diseases. The Memorandum of Understanding marks a milestone in a long partnership to advance scientific discovery and signals researchers to the availability of a remarkable platform on which to conduct experiments. Continue reading →

The National Institutes of Health (NIH) and NASA have entered into an agreement that helps American scientists utilize the International Space Station to answer questions about human health and diseases. The Memorandum of Understanding marks a milestone in a long partnership to advance scientific discovery and signals researchers to the availability of a remarkable platform on which to conduct experiments. Continue reading →